
Invest in the Best
Check two-year estimates on Price, Revenue & Earnings
| Open | 887.90 |
| High | 929.00 |
| Low | 887.00 |
| Prev Close | 875.70 |
| Volume | 3,92,371 |
| VWAP(₹) | 908.10 |
| PE Ratio(x) | 12.24 |
| EPS - TTM(₹) | 75.47 |
| MCap(₹ Cr.) | 8,330.51 |
| MCap Rank | 6 |
| PB Ratio(x) | 2.60 |
| Div Yield(%) | 1.62 |
| Face Value(₹) | 10.00 |
| 52W High(₹) | 1,297.00 |
| 52W Low(₹) | 755.55 |
| MCap/Sales | 1.49 |
| Beta(1 Month) | 1.39 |
| BV/Share(₹) | 347.71 |
ROE Outperforming 5 Year Average
Company delivered ROE of 21.7% in year ending Mar 31, 2026 outperforming its 5 year avg. of 14.21%. (Source: Consolidated Financials)Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 22.69% outperformed its 3 year CAGR of 9.46%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.27% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)Sharda Cropchem Share Price Update
Sharda Cropchem Ltd. share price moved up by 5.45% from its previous close of Rs 875.70. Sharda Cropchem Ltd. stock last traded price is 923.35
| Share Price | Value |
|---|---|
| Today/Current/Last | 923.35 |
| Previous Day | 875.70 |
Found Insights useful?
| 1 Day | 5.45% |
| 1 Month | -19.69% |
| 3 Months | -10.63% |
| 1 Year | 13.39% |
| 3 Years | 64.69% |
| 5 Years | 146.42% |
5 Analysts
| Ratings | Current | 1W Ago | 1M Ago | 3M Ago |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 |
| Sell | - | - | - | - |
| Strong Sell | - | - | - | - |
| # Analysts | 5 | 5 | 5 | 6 |
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Income | 2,087.35 | 1,310.00 | 958.49 | 1,017.30 | 1,853.76 |
| Total Income Growth (%) | 59.34 | 36.67 | -5.78 | -45.12 | 99.34 |
| Total Expenses | 1,664.80 | 1,131.05 | 872.42 | 847.61 | 1,597.25 |
| Total Expenses Growth (%) | 47.19 | 29.65 | 2.93 | -46.93 | 80.77 |
| EBIT | 422.55 | 178.95 | 86.07 | 169.70 | 256.51 |
| EBIT Growth (%) | 136.12 | 107.92 | -49.28 | -33.85 | 453.02 |
| Profit after Tax (PAT) | 318.64 | 145.12 | 74.31 | 142.78 | 203.57 |
| PAT Growth (%) | 119.56 | 95.28 | -47.95 | -29.86 | 553.54 |
| EBIT Margin (%) | 20.24 | 13.66 | 8.98 | 16.68 | 13.84 |
| Net Profit Margin (%) | 15.27 | 11.08 | 7.75 | 14.04 | 10.98 |
| Basic EPS (₹) | 35.32 | 16.09 | 8.24 | 15.83 | 22.57 |
All figures in Rs Cr, unless mentioned otherwise
Beating 3 Yr Revenue CAGR
Company's annual revenue growth of 22.69% outperformed its 3 year CAGR of 9.46%. (Source: Consolidated Financials)Employee & Interest Expense
Company has spent less than 1% of its operating revenues towards interest expenses and 1.27% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Total Assets | 5,780.30 | 4,724.85 | 4,038.32 | 4,350.83 | 3,743.13 |
| Total Assets Growth (%) | 22.34 | 17.00 | -7.18 | 16.23 | 30.70 |
| Total Liabilities | 2,643.26 | 2,223.87 | 1,800.83 | 2,118.45 | 1,830.34 |
| Total Liabilities Growth (%) | 18.86 | 23.49 | -14.99 | 15.74 | 46.51 |
| Total Equity | 3,137.04 | 2,500.98 | 2,237.49 | 2,232.37 | 1,912.79 |
| Total Equity Growth (%) | 25.43 | 11.78 | 0.23 | 16.71 | 18.47 |
| Current Ratio (x) | 1.86 | 1.81 | 1.86 | 1.65 | 1.69 |
| Total Debt to Equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
| Contingent Liabilities | 0.00 | 282.37 | 374.84 | 378.77 | 293.82 |
All figures in Rs Cr, unless mentioned otherwise
| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Net Cash flow from Operating Activities | 655.69 | 603.62 | 341.30 | 328.28 | 267.10 |
| Net Cash used in Investing Activities | -513.07 | -510.06 | -393.49 | -145.16 | -207.89 |
| Net Cash flow from Financing Activities | -118.28 | -67.93 | -36.91 | -97.10 | -90.96 |
| Net Cash Flow | 92.61 | 39.87 | -89.02 | 119.67 | -28.86 |
| Closing Cash & Cash Equivalent | 219.82 | 127.21 | 87.34 | 176.36 | 56.69 |
| Closing Cash & Cash Equivalent Growth (%) | 72.80 | 45.65 | -50.48 | 211.08 | -33.73 |
| Total Debt/ CFO (x) | 0.00 | 0.00 | 0.01 | 0.01 | 0.14 |
All figures in Rs Cr, unless mentioned otherwise
Increase in Cash from Investing
Company has used Rs 513.07 cr for investing activities which is an YoY increase of 0.59%. (Source: Consolidated Financials)| Annual | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Return on Equity (%) | 21.70 | 12.17 | 1.42 | 15.32 | 18.26 |
| Return on Capital Employed (%) | 25.25 | 13.88 | 3.07 | 18.28 | 22.73 |
| Return on Assets (%) | 11.77 | 6.44 | 0.78 | 7.85 | 9.33 |
| Interest Coverage Ratio (x) | 672.65 | 311.10 | 94.68 | 151.52 | 321.65 |
| Asset Turnover Ratio (x) | 1.00 | 0.99 | 0.75 | 0.85 | 0.94 |
| Price to Earnings (x) | 11.53 | 16.92 | 90.91 | 12.92 | 15.90 |
| Price to Book (x) | 2.50 | 2.06 | 1.29 | 1.98 | 2.90 |
| EV/EBITDA (x) | 6.45 | 7.52 | 8.21 | 6.20 | 7.62 |
| EBITDA Margin (%) | 22.43 | 15.16 | 10.83 | 16.89 | 19.88 |
ROE Outperforming 5 Year Average
Company delivered ROE of 21.7% in year ending Mar 31, 2026 outperforming its 5 year avg. of 14.21%. (Source: Consolidated Financials)Found Financials useful?
No Data Available
Global Meltdown1st Jan 2008 to 10th Nov 2008
Covid Crisis1st Feb 2020 to 31st Mar 2020
| R1 | - | Pivot - | S1 | - |
| R2 | - | S2 | - | |
| R3 | - | S3 | - |
| 5 Days | 14 Days | 28 Days |
| - | - | - |
Choose from Peers
Choose from Stocks
Found Peer Comparison useful?
MF Ownership as on 30 April 2026
579.99
Amount Invested (in Cr.)
1.52%
% of AUM
0.00
% Change (MoM basis)
143.15
Amount Invested (in Cr.)
0.8%
% of AUM
-9.49
% Change (MoM basis)
98.69
Amount Invested (in Cr.)
0.44%
% of AUM
0.00
% Change (MoM basis)
Final
90%
May 13, 2026
Board Meeting
Audited Results & Final Dividend
May 05, 2026
Interim Dividend
60%
Jan 29, 2026
| Announced on | Meeting on |
| May 05, 2026 | May 13, 2026 |
| Audited Results & Final Dividend | |
| Jan 20, 2026 | Jan 29, 2026 |
| Quarterly Results & Interim Dividend | |
| Oct 20, 2025 | Oct 30, 2025 |
| Quarterly Results | |
| Jul 17, 2025 | Jul 25, 2025 |
| Quarterly Results | |
| May 05, 2025 | May 14, 2025 |
| Audited Results & Final Dividend | |
| Announced on | Ex-Date | Dividend% |
| Jan 29, 2026 | Feb 06, 2026 | 60% |
| May 14, 2025 | Aug 07, 2025 | 60% |
| Jan 24, 2025 | Feb 06, 2025 | 30% |
| May 10, 2024 | Aug 02, 2024 | 30% |
| May 13, 2026 | - | 90% |
No Data Available
No Data Available
No Data Available
| Announced on | Meeting on |
| Jul 01, 2025 | Aug 14, 2025 |
| - | |
| Jul 03, 2024 | Aug 09, 2024 |
| Book closure from Aug 3, 2024 to Aug 3, 2024 | |
| Dec 12, 2023 | Jan 17, 2024 |
| - | |
| Jun 21, 2023 | Aug 02, 2023 |
| Annual General Meeting | |
| Jun 28, 2022 | - |
| Book closure from Jul 27, 2022 to Jul 27, 2022 | |
Sharda Cropchem Ltd., incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 8,330.51 Crore) operating in Pesticides/Agro Chemicals sector.
Industry
Key Indices Listed On
BSE SmallCap, BSE Commodities, BSE AllCap, Nifty Smallcap 500, Nifty Microcap 250
Address
Prime Business Park,Dashrathlal Joshi Road,Vile Parle (West),Mumbai, Maharashtra - 400056
Ramprakash V Bubna
Chairman & Managing DirectorAshish R Bubna
Whole Time DirectorManish R Bubna
Whole Time DirectorSharda R Bubna
Whole Time DirectorDATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).
DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.
By using this site, you agree to the Terms of Service and Privacy Policy.